Contact us

EMA EU GMP CDMO Companies
European Pharmaceutical Manufacturing Services

Your Trusted Partners for European Pharmaceutical Manufacturing and Development

Applied Filters:EMA (EU GMP)×Clear All
Showing 133 facilities
Laboratorio REIG JOFRE, SA (TOLEDO PLANT)
Spain

Laboratorio REIG JOFRE, SA (TOLEDO PLANT)

LABORATORIO REIG JOFRE SA

Betalactam antibiotics (FDF) development and manufacturing state-of-the-art facilities.

MARKETS: EMA (EU), ANVISA (Brazil), ISP (Chile), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), INVIMA (Colombia), SFDA (Saudi Arabia), TGA (Australia)

REGION: APAC, MENA, LATAM, Europe, North America

COMPLIANCE: DIGEMID, ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BATCH SIZE: Large, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use

CONTROLLED SUBSTANCES: Lowest potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Laboratorios Grifols | Barcelona Plant
Spain

Laboratorios Grifols | Barcelona Plant

Grifols International

Sterile manufacturing solutions (small molecules) in flexible bags and vials.

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

White Raven - Legiapark
Belgium

White Raven - Legiapark

White Raven

Fill and finish site dedicated to GMP Formulation and the Aseptic filling of Sterile Liquid Injectables.

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: EMA (EU)

REGION: Europe

USE: Human

BSL (Biological Safety Level): 1, 2

SERVICES: Manufacturing services, Packaging

BATCH SIZE: Small, Medium

COMPLIANCE: EMA (EU GMP)

CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)
Spain

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)

LABORATORIO REIG JOFRE SA

Injectable (lyo and liquid) and Liquid manufacturing facilities.

BSL (Biological Safety Level): 3, 1, 2

MARKETS: EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MHRA (UK), INVIMA (Colombia), MFDS (South Korea), TGA (Australia)

REGION: Europe

BATCH SIZE: Large, Medium

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

COMPLIANCE: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), ECOVADIS, INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Sylentis
Spain

Sylentis

Sylentis

Oligonucleotide manufacturer.

COMPLIANCE: ICH, FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

MARKETS: EMA (EU), FDA (USA)

REGION: Europe

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: OLIGONUCLEOTIDES

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

VIVEbiotech
Spain

VIVEbiotech

VIVEbiotech

Your leading GMP-certified CDMO exclusively dedicated to the production of lentiviral vectors.

MARKETS: EMA (EU), FDA (USA), MHRA (UK)

REGION: Europe

COMPLIANCE: FDA (cGMP), French Service-Public (CIR), EMA (EU GMP), MHRA (UK GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

BSL (Biological Safety Level): 1, 2

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

CATEGORY / PRODUCT: BIOLOGICS

Pharmaron API Commercial Synthesis Cramlington (UK)
United Kingdom

Pharmaron API Commercial Synthesis Cramlington (UK)

Pharmaron

Commercial API Small Molecules Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

REGION: Europe

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

HIPRA BIOTECH SERVICES | Amer
Spain

HIPRA BIOTECH SERVICES | Amer

HIPRA Biotech Services

End-to-end internal capabilities from cell line development to commercial manufacturing.

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS

BAG Health Care
Germany

BAG Health Care

BAG Health Care GmbH

Parenteral F&F provider for vials in small to mid sized batches.

MARKETS: EMA (EU), MHRA (UK), TGA (Australia)

REGION: Europe

USE: Human, Veterinary

BSL (Biological Safety Level): 1

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

BATCH SIZE: Small, Medium

COMPLIANCE: EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Lifecore Injectables CDMO
United States

Lifecore Injectables CDMO

Lifecore Biomedical

CDMO that manufactures clinical & commercial sterile injectable drug products.

BSL (Biological Safety Level): 3, 1, 2

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CONTROLLED SUBSTANCES: Lowest potential for abuse

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

REGION: North America

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

53Biologics Production Plant
Spain

53Biologics Production Plant

53Biologics

53Biologics is a Spanish CDMO specialized in decoding the production of biologicals, from DNA to proteins.

MARKETS: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: BIOLOGICS

Laboratorios Grifols | Murcia Plant
Spain

Laboratorios Grifols | Murcia Plant

Grifols International

Sterile manufacturing solutions (small molecules) in flexible bags.

MARKETS: EMA (EU), FDA (USA), ANVISA (Brazil), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)

SERVICES: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+63 more facilities

Create free account

To succeed in the European pharmaceutical market, companies must meet the rigorous quality and regulatory expectations set by the European Medicines Agency (EMA). That’s why pharma and biotech companies partner with experienced EMA EU GMP CDMO companies to ensure their products are developed and manufactured in full compliance with European pharmaceutical manufacturing standards.

With EMA-certified facilities, robust quality systems, and global submission support, these CDMOs help bring your product to EU and international markets safely and efficiently.

How to Choose EMA EU GMP CDMO Companies

When selecting EMA EU GMP CDMO companies, consider:

Verifying compliance credentials with EU-GMP certification: Issued by national regulatory authorities in the EU.

Ensuring global audit readiness via Successful EMA inspections: And audit readiness for global compliance.

Supporting clinical-to-market transitions with Experience with both clinical and commercial-scale manufacturing: Covering all development phases.

Establishing robust batch oversight through Proven quality systems: In line with ICH Q7/Q8/Q10 standards.

Streamlining regulatory filings via Support for EU submissions: MAA, CEP, IMPD, and ASMF documentation.

Enabling batch release in Europe through Pharmacovigilance and Qualified Person (QP) release capabilities: Meeting EEA requirements.

Leveraging strategic regional infrastructure via Facility location within the European Economic Area (EEA): Facilitating European supply chain efficiency.

The right CDMO ensures your project meets both technical and regulatory requirements for entry into the European market.

Key Services Offered by European Pharmaceutical Manufacturing Partners

Top-tier European pharmaceutical manufacturing providers typically offer:

Optimizing solid and liquid processes via GMP formulation development and process optimization: Designed for scale and stability.

Manufacturing diverse active ingredients and finished products, including Manufacturing of oral solids, liquids, injectables, biologics, and APIs: Across multiple dosage forms.

Verifying product specifications with Analytical testing and EU-compliant documentation: Supporting quality control requirements.

Processing sterile and non-sterile formats through Sterile and non-sterile fill-finish capabilities: In compliant cleanroom suites.

Facilitating commercial market entry via Batch certification and QP release for clinical and commercial supply: Ensuring EU market authorization compliance.

Assisting clinical trial approvals through Support for EU submissions: Including IMPDs and CTAs.

Executing smooth scale-up operations via Technology transfer, scale-up, and process validation: Minimizing technical risks.

Securing end-to-end tracebility with Packaging and serialization according to EU FMD regulations: Preventing falsified medicines.

These services ensure full regulatory alignment and market readiness for EU and global supply.

Advantages of Partnering with EMA EU GMP CDMO Companies

Collaborating with experienced EMA EU GMP CDMO companies offers major advantages:

Securing European market entry via EU market access: Via compliant manufacturing and QP certification.

Achieving international health authority trust with Global regulatory acceptance: Supported by high EMA quality standards.

Preventing regulatory disruptions through Reduced risk of delays or rejections: Due to audit-proven processes.

Formulating novel biopharmaceuticals with Support for complex drug formats and emerging therapies: Including cell and gene therapies.

Streamlining overall operations via Seamless integration: Of development, manufacturing, and submission workflows.

European manufacturing quality is globally recognized — and your CDMO partner should reflect that.

EMA EU GMP CDMO Companies

Some of the most trusted EMA EU GMP CDMO companies include:

CDM Lavoisier: Human drugs CDMO specialized in the manufacturing of glass ampoules, glass vials and plastic (BFS) ampoules. [See CDMO profile]

Cenexi: CDMO that specializes in the production of sterile highly potent injectables, mainly against cancer. [See CDMO profile]

FAES FARMA: Developer and manufacturer of human medicinal products. [See CDMO profile]

ASCIL Biopharm: GMP facility fully equipped for R&D and pharmaceutical development. [See CDMO profile]

Grifols: Sterile manufacturing solutions (small molecules) in flexible bags and vials. [See CDMO profile]

VIVUNT PHARMA: CDMO for sterile oncology drugs. [See CDMO profile]

Liof Pharma: Reliable CDMO partner for aseptic manufacturing and lyophilization of biologics and injectable drugs. [See CDMO profile]

Reig Jofre: Injectable (lyo and liquid) and liquid manufacturing facilities. [See CDMO]

Pharmaloop: Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets. [See CDMO profile]

Glatt Pharmaceutical Services GmbH Co. & KG: cGMP-compliant CDMO for end-to-end services in complex oral solid dosage forms. [See CDMO profile]

Adragos Pharma: Over 100 years of experience delivering customer-focused manufacturing and first-class service. [See CDMO profile]

CARBOGEN AMCIS: Highly potent APIs development and small-scale cGMP production including chromatography and lyophilization. [See CDMO profile]

Apeloa Pharmaceutical Co., Ltd: Development and manufacturing of APIs, intermediates and registered starting materials. [See CDMO profile]

Mabion cGMP Facility: Development and GMP manufacturing of biotherapeutics including monoclonal antibodies and recombinant protein products. [See CDMO profile]

Ophtapharm, a Sentiss Company: Ophthalmic and otic solutions, suspensions, emulsions, ointments and gels. FDA-approved facility. [See CDMO profile]

Cellex Cell Professionals: CGT CDMO specialized in cell manufacturing and collection of starting materials. [See CDMO profile]

AdhexPharma SAS: CDMO for transdermal patches and oromucosal films. [See CDMO profile]

MENADIONA S.L: APIs, intermediates and fine chemicals; specialized in transferring R&D projects into full cGMP manufacturing. [See CDMO profile]

Content Group: Tubilux Pharma manufacturing facility. [See CDMO profile]

TRADICHEM INDUSTRIAL SERVICES: HIPERING® technology enabling lean manufacturing. [See CDMO profile]

53Biologics Production Plant: Biologics production from DNA to proteins, from preclinical to cGMP manufacturing. [See CDMO profile]

Rioja Nature Pharma: CDMO specializing in nutraceuticals and food supplements. [See CDMO profile]

HIPRA BIOTECH SERVICES: End-to-end capabilities from cell line development to commercial manufacturing. [See CDMO profile]

Skyepharma: Development and delivery of oral technologies for pharma, biotech and consumer health. [See CDMO profile]

ChemCon GmbH: CDMO for APIs and fine chemicals with expertise in scaling R&D projects to cGMP manufacturing. [See CDMO profile]

VIVEbiotech: GMP-certified CDMO dedicated to lentiviral vector production. [See CDMO profile]

BAG Health Care: Parenteral fill & finish for vials in small to mid-size batches and investigational products. [See CDMO profile]

Lannett CDMO: OSD and liquid manufacturing capabilities in Seymour, Indiana. [See CDMO profile]

Basic Pharma Manufacturing: Analytical testing and regulatory support tailored to project needs. [See CDMO profile]

HISTOCELL S.L: Developer and manufacturer of cell therapies (iPSCs, MSCs, secretomes, exosomes) plus medical devices and dermocosmetics. [See CDMO profile]

Lukas Heil-Betriebsstätte: High-performance GMP facility for sterile and aseptic liquids, especially glass ampoules. [See CDMO profile]

Laboratori Alchemia SRL: Production from lab scale for complex synthetic products to hundreds of kilograms per year. [See CDMO profile]

Cambrex: Specialists in late-phase and commercial API development and cGMP manufacturing. [See CDMO profile]

Aenova Group: Competence center for solids, semisolids, liquids and clinical services. [See CDMO profile]

Pharmaron: Commercial small molecule API synthesis. [See CDMO profile]

Darnytsia Kyiv: Advanced facilities, strict quality control and expert staff for reliable, compliant solutions. [See CDMO profile]

White Raven: Fill & finish site dedicated to GMP formulation and aseptic filling of sterile liquid injectables. [See CDMO profile]

Sidefarma: Specialist in small and medium batch manufacturing for regulated markets following EU quality standards. [See CDMO profile]

Sylentis: Oligonucleotide manufacturer. [See CDMO profile]

These CDMOs combine quality infrastructure with regulatory experience to ensure EU market success.

Related Information

You may also be interested in:

FDF CDMO Services | Finished Dosage Forms Contract Manufacturing

Biologics CDMO Companies | Biopharmaceutical Contract Manufacturing

Chemical CMO companies | Custom Synthesis and Chemical CMO Solutions

FDA cGMP CDMO Companies | FDA Compliant Manufacturing Services

HPAPI CDMO Companies | Highly Potent API Manufacturing Services

Human Drugs CDMO Companies | Human Medicinal Products Contract Manufacturing Services

Let MAI CDMO Help You Find the Right EMA EU GMP CDMO Partner

At MAI CDMO, we connect pharma and biotech companies with the most qualified EMA EU GMP CDMO companies offering world-class European pharmaceutical manufacturing services. Whether you´re preparing for an EU clinical trial, submitting a marketing authorization application, or scaling to commercial supply, we’ll help you find a trusted partner to ensure EU-GMP compliance every step of the way.

Need an EU-compliant manufacturing solution? Contact us today and find your ideal European CDMO partner.